$RUN

Abajian Danny sold $218K of RUN

Abajian Danny (Chief Financial Officer) sold 16,495 shares of Sunrun Inc. (RUN) at $13.19 ($0.22M total) on 2026-07-06.

Original reporting
SEC EDGAR · Abajian Danny
Published Jul 7, 2026, 9:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 7, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RUN
Neutral
medium confidence
Mentioned
$RUN
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RUNNeutralLow
01

Why it matters

The disclosure updates the insider-trading record for RUN but does not include any accompanying corporate event (earnings, guidance, contract, or investigation).

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a sustained repricing.

03

What to watch

The article provides only the sale details; it does not include any concurrent purchases, option exercises, or broader insider activity that would strengthen the signal.

Relevance 4/10Novelty 5/10Timing: after-hours/filing timestamp (2026-07-07) for the 2026-07-06 sale

Background

This is an SEC Form 4 insider transaction filed by Sunrun’s CFO, reporting an open-market sale.

Company-level read

Ticker impact

$RUNNeutralMedium confidence
Context

Sunrun CFO Abajian Danny filed a Form 4 open-market sale of 16,495 shares at $13.1865 on 2026-07-06.

Expected impact

Low near-term impact; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a primary-source Form 4, but it is an open-market sale with no stated company-specific catalyst and no 10b5-1 plan indicated.

Market effects

No direct sector read-through; this is an individual insider transaction rather than a sector/regulatory development.

None indicated.

None indicated.

Counterpoint

The absence of a stated 10b5-1 plan could make the sale look more discretionary, but insider sales are often driven by taxes or diversification rather than bearish fundamentals.

Key entities

  • Sunrun Inc.

    Subject of the Form 4 insider transaction; ticker RUN.

  • Abajian Danny

    Sunrun CFO who sold 16,495 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FSLRMed

First Solar Climbs 4% as Truist Buy Call and December Tariff Floor Reset Panel Pricing Outlook; Enphase Energy and Sunrun Hold Flat

First Solar (FSLR) stock rose 4% to $186.21 after a Truist upgrade to Buy with a $270 price target, citing improved pricing and valuation. The U.S. Department of Commerce's Section 232 trade decision sets a minimum import price for foreign solar panels, benefiting First Solar. Enphase (ENPH) and Sunrun (RUN) stocks remained flat. First Solar's thin-film technology and U.S. manufacturing position it favorably against competitors.

$RUNHigh

Goldman Sachs Cut Its Sunrun Target. It Still Sees [44%] Upside

Goldman Sachs and Citi reduced their price targets for Sunrun (RUN) to $11 and $14, respectively, while maintaining Buy ratings. Analysts anticipate a decline in Sunrun's EPS from $1.71 in 2025 to $1.00 by 2027. Sunrun's stock closed at $7.61 on Oct. 7, a 52-week low. The cuts reflect lower expectations for near-term growth and cash generation.

$RUNMed

Why is Sunrun stock sliding today?

Sunrun (RUN) stock fell 2.0% to $7.46 in pre-market trading, continuing a downtrend after price target cuts from Goldman Sachs and Citi, citing lower near-term growth expectations. The stock hit a 52-week low of $7.42, down 62% over the past year. Analysts maintained Buy ratings but reduced targets to $11 and $14, respectively. A large options trade suggests hedging against further downside. The broader market decline and policy uncertainty also weighed on the stock.